T&R Biofab Co., Ltd Logo

T&R Biofab Co., Ltd

Develops 3D bioprinted scaffolds for tissue repair in orthopedics, surgery, and dentistry.

246710 | KO

Overview

Corporate Details

ISIN(s):
KR7246710008
LEI:
Country:
South Korea
Address:
경기도 시흥시 마유로 96, 시흥시
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

T&R Biofab Co., Ltd. is a biomedical engineering company specializing in regenerative medicine and tissue engineering. Leveraging its proprietary 3D bioprinting technology, the company develops and commercializes products designed for tissue and organ regeneration and reconstruction. Its core offerings include 3D-printed bioresorbable scaffolds, bio-inks, bio-surgical solutions, organoids, and induced pluripotent stem cells (hiPSC). These advanced solutions cater to various medical fields, including orthopedics, plastic surgery, and dentistry, aiming to provide innovative treatments for tissue repair and transplantation.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-09-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-09-16 00:00
Registration Form
[기재정정]증권신고서(지분증권) (2025.10)
Korean 3.9 MB
2025-09-16 00:00
Prospectus
[기재정정]투자설명서
Korean 3.8 MB
2025-09-15 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-09-12 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 97.7 KB
2025-09-09 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 96.0 KB
2025-09-08 00:00
Share Issue/Capital Change
유상증자1차발행가액결정
Korean 8.0 KB
2025-09-08 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유무상증자결정)
Korean 54.6 KB
2025-09-08 00:00
Share Issue/Capital Change
[발행조건확정]증권신고서(지분증권)
Korean 568.9 KB
2025-09-08 00:00
Prospectus
투자설명서
Korean 3.7 MB
2025-09-08 00:00
Share Issue/Capital Change
권리락 (유상증자)
Korean 3.5 KB
2025-09-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 123.1 KB
2025-08-22 00:00
Registration Form
[기재정정]증권신고서(지분증권) (2025.10)
Korean 4.9 MB
2025-08-21 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.9 MB

Automate Your Workflow. Get a real-time feed of all T&R Biofab Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for T&R Biofab Co., Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for T&R Biofab Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

RxSight, Inc. Logo
Develops a light-adjustable lens for customized vision correction after cataract surgery.
United States of America
RXST
Safe S.A. Logo
Appears to operate in the orthopedics sector; specific details are unavailable.
France
ALSAF
Sanara MedTech Inc. Logo
Develops med-tech for surgical, wound, and skin care, plus telehealth for providers.
United States of America
SMTI
SANYU CO.,LTD. Logo
A manufacturer of medical analytical equipment focused on R&D for next-generation systems.
Japan
5697
Scandinavian ChemoTech AB Logo
Develops electroporation tech to enhance chemotherapy for cancer, targeting Asia & the Middle East.
Sweden
CMOTEC
Scandinavian Real Heart AB Logo
Develops a total artificial heart that mimics natural heart function for heart failure patients.
Sweden
HEART
Schott Pharma Logo
Drug containment & delivery systems (syringes, vials) for the global pharma/biotech industry.
Germany
1SXP
SD BIOSENSOR  INC. Logo
South Korea
137310
SeaStar Medical Holding Corp Logo
Develops a device-based therapy for hyperinflammation in critically ill ICU patients.
United States of America
ICU
SEJONG MEDICAL Co.Ltd., Logo
South Korea
258830

Talk to a Data Expert

Have a question? We'll get back to you promptly.